Latest News & Features
Americas
The appeals court reversed a jury verdict, finding the antibody-drug conjugate patent lacked adequate written description and enablement support from its priority application. 3 December 2025
Careers
Firm adds ex-DLA Piper litigator, who brings “deep technical experience” and “a proven track record” in complex patent and trade secrets cases. 3 December 2025
Careers
The firm has hired a former chemical engineer with clients in aviation, medical devices, and industrial manufacturing, who also led Kilpatrick’s patent best practices committee. 3 December 2025
Europe
The move could unlock billions in life sciences collaborations and position the UK to rival the US and China. But turning a famously conservative, patient-safety-first institution into a commercially savvy innovation hub will be no small feat. 2 December 2025
Americas
Brazil’s pharmaceutical IP landscape is shifting fast, and Juliana Neves of Licks unpacks how new reforms, guidelines, and rulings are resetting the strategic ground rules for innovators. 2 December 2025
Europe
The Paris Local Division says Merz ran out of time to stop Viatris' multiple sclerosis generic, clarifying the court’s urgency standards in the process. 1 December 2025
Europe
Joining an expanding IP litigation practice, the new partner adds experience in patent, SPC and multi-jurisdictional disputes across pharma, technology, and medical devices. 1 December 2025
Europe
With EU trilogues deadlocked over the package, the future of drug exclusivities and access-linked obligations hangs in the balance. Jackie Mulryne and Paul Ranson of Morgan Lewis pinpoint the flashpoints to watch as negotiators push for a year-end deal. 28 November 2025
Europe
The Court of Appeal has overturned a ruling that revoked the pharma company’s cholesterol-lowering antibody patent, clarifying key principles for assessing inventive step. 27 November 2025
Americas
Director Squires rescinds previous guidelines and clarifies that there is no separate, modified inventorship standard for AI-assisted inventions. 27 November 2025